Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Inhibiteurs du récepteur du facteur de croissance épidermique (Epidermal Growth Factor Receptor Inhibitors = EGFRI): Médicaments qui sont dirigés contre l'EGFR et l'inhibent, et qui englobent des anticorps monoclonaux et des inhibiteurs de tyrosine kinases à faible poids moléculaire.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings